Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
67
NCT03035643
DARTS I Feasibility Study
Phase: N/A
Role: Lead Sponsor
Start: Mar 5, 2017
Completion: Mar 19, 2024
NCT03397251
DARTS I: Feasibility, Safety, and Performance Trial
Start: Mar 7, 2018
Completion: Jan 23, 2024
NCT06023186
Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Start: Nov 3, 2023
Completion: Sep 30, 2026